In an exclusive interview with People, the NFL Legend, Dan Marino shared how minor changes in body, which, usually go unnoticed lead to liver disease, like it did for him. Marino did not notice any symptoms in his routine checkup in 2007, but he did feel a "little fatigued". He also "was not rally working out as much as" he usually would. "These are the things I kind of noticed," he said, now, 64. "Then they told me I had a fatty liver. I had MASH."

What Is MASH?

It is a liver disease, short for metabolic dysfunction-associated steatohepatitis, which was formerly called the nonalcoholic fatty liver disease. This happens when excess fat cells accumulate in the liver, causing chronic inflammation that leads to cirrhosis and liver cancer, as notes the Cleveland Clinic.

He informed People that the doctors "right away said that can be reversible, it can be taken care of". However, for him, it was to "work out" or to "lose weight", he noted.

Also Read: Congo Ebola Outbreak Caused By The Zaire Strain So Far Has 28 Deaths, Confirms WHO

The NFL legend is current part of Novo Nordisk's Unordinary Stories campaign, where athletes like him, share their unique health journey.

A Support System

Marino shared that his journey and health improvement also is credited to the support he got from his friends and family who helped him prioritized his health. Former teammate Terri Kirby also trained him at his nearby gym and his wife Claire joined him for night walks and bike rides. He also said in the campaign video that his wife helped him with "doctor's appointments, being on time, and making sure I'm doing things right".

Also Read: Every Year, They Return To Lake Minnetonka: Four Survivors Who Beat Cancer And Celebrate Life

Like most of us must have heard that it takes a village to raise a child, Marino echoes the same emotions. It does take a village to bring someone back to health too. "It is the people that love you and you love them. It feels like a little village," he says.

A Consistent Focus On Health

After his diagnosis, he soon realized that the focus on his health needs to be consistent. “It's the exercise, riding bike, walking, and diet, and then getting back to just being consistent — waking up and making sure you gotta do something every day.”

He also thinks that it is the diet that caused his MASH. He shared with People that while he played football, he had weigh-ins, but after he retired in 2000, he "kind of" let his diet go. "That's really where it kind of came about," he said.

A Diet To Fix

He shared that his doctor recommended him the Mediterranean diet to "cut back on the wine and pizza and candy, ice cream, those kind of things, you know - you can't eat those as much".

For people, he has a message: “if you get diagnosed with fatty liver and MASH, doing the things you need to do, like I talked about — diet, working out — and staying consistent with it, that's what our message really is.”

All such practices has made him get better. "I get the ultrasounds and all that every year, and so far it's been fine [and it is] gonna get better and better and better," he says.

If you struggle with anxiety or trouble sleeping, your doctor may prescribe lorazepam or alprazolam (commonly known as Xanax). These belong to a class of drugs called benzodiazepines, which work by enhancing the effects of gamma-aminobutyric acid (GABA), a chemical in the brain that helps calm the nervous system.

While both medicines are often used to ease anxiety symptoms, alprazolam is also prescribed to control seizures in people with epilepsy. But despite their short-term effectiveness, one clinical psychologist has warned that depending on these medications without addressing underlying issues can be harmful in the long run.

‘Benzodiazepines Don’t Solve the Root Cause,’ Says Psychologist

Spanish psychologist Fernando Azor, known for sharing mental health insights on TikTok, cautioned his followers about the overuse of benzodiazepines.

In a recent video, Azor explained that while drugs such as lorazepam and alprazolam can help calm anxiety attacks, they only mask symptoms rather than helping people understand what triggers their distress.

He added, “People experiencing anxiety crises often struggle to face the physical sensations, such as a racing heart, blurred vision, or nervousness—that come with anxiety. We automatically see them as dangerous or negative, but in reality, they are natural bodily responses to stress.”

According to Azor, perceiving these sensations as something to eliminate immediately can create a cycle of avoidance and dependency, rather than resilience.

Why Relying on Medication Alone Can Backfire

Azor warned that people often reach for these drugs because they take effect quickly, especially when taken under the tongue. This offers temporary relief, but it reinforces the idea that anxiety symptoms must be avoided rather than understood.

He compared it to feeling hunger: “Being hungry can be unpleasant, but it’s not wrong—it signals the body’s needs. Anxiety works similarly. It’s uncomfortable, but not necessarily harmful.”

By suppressing symptoms too quickly, people may avoid learning coping strategies, which can lead to increased distress and reliance on medication.

Learning to Manage Anxiety Through Therapy

The psychologist highlighted that psychotherapy can help individuals build tolerance for uncomfortable sensations instead of fearing them. Through practical exercises and guided experiences, people can learn to sit with their symptoms and understand them logically and emotionally.

“Therapy helps people see that feeling anxious doesn’t always mean something is wrong,” Azor said. “With the right tools, you can live with those sensations without needing to eliminate them instantly.”

When to Seek Professional Help

If you have been feeling persistently anxious, struggling to control your emotions, or having difficulty sleeping for six months or longer, experts recommend speaking to your general practitioner (GP).

According to NHS guidance, treatment for anxiety may include:

• Medications designed to manage anxiety symptoms
• Talking therapies such as cognitive behavioural therapy (CBT)
• Referral to mental health specialists for more tailored support

While benzodiazepines like lorazepam and alprazolam can offer short-term relief, mental health experts warn that they should not replace long-term coping mechanisms. Building emotional awareness and resilience through therapy and self-regulation remains key to managing anxiety sustainably.

The World Health Organization (WHO) has raised concern over the continued spread of Mpox (formerly known as monkeypox) across Africa and other regions. In the past six weeks alone, 17 African nations have reported active transmission. Between September 14 and October 19, there were 2,862 confirmed infections and 17 related deaths, according to WHO’s 59th multi-country situation report released on October 30.

The Democratic Republic of Congo, Liberia, Kenya, and Ghana have reported the highest number of cases. Infections have increased notably in Kenya and Liberia, while the Democratic Republic of Congo has seen a slight decline and Ghana is beginning to show early signs of improvement.

What Is Mpox and How Does It Spread?

Mpox, previously known as monkeypox, is a viral infection caused by the monkeypox virus, which belongs to the Orthopoxvirus genus. The World Health Organization (WHO) identifies two main clades of the virus, Clade I (subdivided into Ia and Ib) and Clade II (IIa and IIb). The widespread outbreak seen during 2022–2023 was primarily linked to Clade IIb.

Typical symptoms include skin rashes or lesions that last two to four weeks, along with fever, body aches, swollen lymph nodes, fatigue, and headaches.

The infection spreads through close physical contact with an infected person, contaminated objects, or animals carrying the virus. Transmission from a pregnant woman to her baby can also occur.

How Serious Is the Global Mpox Situation Now?

According to the World Health Organization (WHO), a total of 42 countries reported 3,135 confirmed Mpox infections and 12 related deaths in September, with more than four-fifths of all cases recorded in Africa. While most regions have seen infection rates ease, the European and South-East Asian regions are now showing a slight increase.

The WHO stated that all variants, or clades, of the monkeypox virus (MPXV) remain in circulation worldwide. Experts caution that if emerging outbreaks are not swiftly controlled, ongoing community transmission may occur.

It is worth noting that in the same month, the WHO ended Mpox’s designation as a Public Health Emergency of International Concern (PHEIC) after observing a consistent decline in new infections, particularly in heavily affected African countries.

Where Has the New Clade Ib Variant Been Found?

The Clade Ib form of the Mpox virus has been newly detected in Malaysia, Namibia, the Netherlands, Portugal, and Spain. Additional imported cases linked to international travellers carrying the same strain have appeared in Belgium, Canada, Germany, Italy, Qatar, and Spain.

Evidence of local transmission—cases without any recent travel exposure, has been confirmed in six countries outside Africa: Italy, Malaysia, the Netherlands, Portugal, Spain, and the United States. In the U.S., three patients hospitalised in California tested positive for the new variant despite no travel history, according to The Guardian, prompting concern among health authorities.

Following these developments, WHO has officially classified these countries as experiencing community-level spread of the Clade Ib MPXV strain.

How Are Countries Responding to the Renewed Spread of Mpox?

WHO continues to assess the global Mpox threat as moderate among men who have sex with men (MSM) and low for the general population. The agency is encouraging governments to sustain surveillance systems, improve testing capabilities, and maintain access to vaccines and treatment options to prevent wider community outbreaks.

Medication recall blood pressure: More than 580,000 bottles of Prazosin Hydrochloride, a commonly prescribed drug for high blood pressure, are being recalled after tests showed potentially unsafe levels of a cancer-linked impurity. The manufacturer has advised patients using the affected medication to reach out to their doctor or pharmacist for guidance.

The recall, issued on October 7 by New Jersey–based Pharmaceuticals USA Inc., involves 55 batches of Prazosin Hydrochloride capsules distributed across the country. The recalled products were sold in 1 mg, 2 mg, and 5 mg doses under the Teva Pharmaceuticals label.

Below is the list of prescription numbers included in the FDA’s recall notice, along with medical advice on what steps to take if your medication is affected.

FDA gov blood pressure medication recall: Which Medicine Is Being Recalled?

Teva Pharmaceuticals USA and Amerisource Health Services have both recalled certain batches of prazosin hydrochloride this month after the U.S. Food and Drug Administration (FDA) detected possible contamination. According to FDA enforcement reports, the affected capsules may contain nitrosamine impurities that exceed the limits set under the agency’s Carcinogenic Potency Categorization Approach (CPCA).

Nitrosamines are a group of chemical compounds that, when present in high amounts, have been linked to an increased risk of cancer. They can form during the production or storage of certain medications.

The FDA classified these recalls as Class II on October 24, indicating that while the affected drugs could cause temporary or reversible health effects, the likelihood of severe harm is considered low.

Current Blood Pressure Medication Recall: Which Lot Are Affected?

The recall applies only to the 1 mg, 2 mg, and 5 mg capsules of prazosin hydrochloride distributed by Teva Pharmaceuticals USA and Amerisource Health Services. It affects select batches identified by specific lot numbers and expiration dates.

The majority of the recalled supply, over 580,000 bottles, came from Teva, with the remainder distributed by Amerisource. Details on the affected products, including the complete list of lot codes and expiry information, are available in the FDA’s official enforcement reports.

As reported by USA Today, the recall includes several dosages and packaging of the medication:

• 1 mg capsules: 181,659 bottles (NDC 0093-4067-01 and 0093-4067-10), from lot numbers 3010544A and 3010545A, with an expiration date of October 2025.
• 2 mg capsules: 291,512 bottles (NDC 0093-4068-01 and 0093-4068-10) from multiple lots, expiring between October 2025 and July 2026.
• 5 mg capsules: 107,673 bottles (NDC 0093-4069-01, 0093-4069-52, and 0093-4069-05) from several batches, with expiration dates extending into 2026.

What To Do If You Have The Recalled Blood Pressure Pills?

If you have any of the recalled prazosin hydrochloride capsules, the FDA recommends contacting your doctor or pharmacist before stopping the medication. In some cases, discontinuing treatment without medical supervision could pose greater health risks than continuing it.

Teva Pharmaceuticals has urged patients to check with their pharmacy to confirm whether their medication is part of the recall and to follow the instructions provided for returning or disposing of the affected pills. The company has already issued recall letters to its customers detailing the process.

Teva noted that no complaints have been reported so far related to the recalled batches. The company added that prazosin, which is used to manage high blood pressure, has several alternative treatments available. “Teva prioritizes patient safety and product quality at every stage of a medicine’s lifecycle,” the statement read.

Patients who have concerns or need further guidance are advised to speak with their prescribing healthcare provider.